TARDBP and Alzheimer disease: Overexpression of TDP-43 in AD transgenic mice has been shown to reduce Aβ plaque number, through mechanisms unclear [33], although TDP-43 depletion increased Aβ uptake by microglia [34], which corresponds to the decreased plaque formation in a mouse model [35].